1 - L1_DOXORUBICINA (DOE) HYDROCHLORIDE

This tender concerns the procurement of L1_DOXORUBICINA (DOE) HYDROCHLORIDE. Doxorubicin hydrochloride is a vital chemotherapy drug used in the treatment of various cancers, including breast cancer, ovarian cancer, bladder cancer, lung cancer, and lymphomas. It functions as an anthracycline antibiotic that works by intercalating DNA and inhibiting the enzyme topoisomerase II, thereby preventing DNA replication and cell division in cancerous cells. The specific details regarding the quantity, quality standards, packaging, and delivery timelines for this pharmaceutical product will be outlined in the full tender documentation. Interested suppliers are expected to provide evidence of their capacity to supply high-quality pharmaceutical products that meet stringent regulatory requirements. This procurement is likely aimed at ensuring a consistent supply of essential medication for healthcare facilities, potentially within a specific region or for a national health program. Bidders should carefully review all specifications, eligibility criteria, and submission instructions to ensure compliance. The tender process will likely involve a thorough evaluation of technical proposals, including product specifications and supplier qualifications, as well as commercial proposals. Further information regarding the tendering authority, contact details, and the deadline for submission will be made available to registered bidders.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Spain, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.